Lo Cascio Giuliana, Vincenzi Marcello, Soldani Fabio, De Carolis Elena, Maccacaro Laura, Sorrentino Annarita, Nadali Gianpaolo, Cesaro Simone, Sommavilla Michele, Niero Valentina, Naso Laura, Grancini Anna, Azzini Anna Maria, Sanguinetti Maurizio, Tacconelli E, Cornaglia Giuseppe
Microbiology and Virology Unit, Department of Pathology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
Infectious Disease Unit, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Front Microbiol. 2020 Jan 31;11:84. doi: 10.3389/fmicb.2020.00084. eCollection 2020.
New fungal species are increasingly reported in immunocompromised patients. (), an ascomycetous fungus formerly called , is intrinsically resistant to echinocandins and is often misidentified.
We describe a cluster of seven infections in hospitalized hematology patients who developed this rare fungemia within a span of 11 months. Three of the seven patients died. Identification of the isolates was determined only with the Saramis database of VitekMS system and sequencing of the internal transcribed spacer (ITS) region. Clonal relatedness of the isolates was determined by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) analysis; clonal correlation between the strains was investigated by means of phylogenetic analysis, based on single-nucleotide variants (SNPs). Clinical presentation, 1-3 β-D-glucan (BG) and galactomannan (GM) antigen results and analysis of possible sources of contamination are also described with a prospective case-control study of the outbreak.
MALDI-TOF MS-Vitek (bioMerieux, Marcy l'Etoile, France) failed to identify the six isolates, while SARAMIS (bioMerieux, Marcy l'Etoile, France) identified the isolates as . Initially, Vitek 2 identified the strains as in two of the seven cases. Molecular identification gave 99% homology with . BG was positive in three out of six patients (range 159 to >523 pg/ml), GM results were always negative. All the isolates were resistant to echinocandins (anidulafungin, micafungin, and caspofungin) and Fluconazole, but susceptible to Flucytosine and Voriconazole. One isolate showed acquired resistance to Flucytosine and Amphotericin B during treatment. Both the correlation-based dendrograms obtained by MALDI-TOF MS (Bruker Daltonics) and MS-Vitek not only clustered six of the seven bloodstream infection (BSI) isolates in the same group, but also showed their strong relatedness. Phylogenetic analysis using SNPrelate showed that the seven samples recorded during the investigation period clustered together. We observed a split between one case and the remainder with a node supported by a -score of 2.3 (-value = 0.021) and 16 mutations unique to each branch.
The use of proteomics for identification and evaluation of strain clonality in outbreaks of rare pathogens is a promising alternative to laborious and time-consuming molecular methods, even if molecular whole-genome sequencing (WGS) typing will still remain the reference method for rare emergent pathogens.
免疫功能低下患者中越来越多地报告了新的真菌物种。(),一种以前称为的子囊菌,对棘白菌素具有内在抗性,并且经常被错误识别。
我们描述了一组7例住院血液学患者的感染病例,这些患者在11个月内发生了这种罕见的真菌血症。7例患者中有3例死亡。仅通过VitekMS系统的Saramis数据库和内部转录间隔区(ITS)区域测序来确定分离株的鉴定。通过基质辅助激光解吸电离飞行时间质谱(MALDI-TOF)分析确定分离株的克隆相关性;基于单核苷酸变异(SNP),通过系统发育分析研究菌株之间的克隆相关性。还通过对该疫情的前瞻性病例对照研究描述了临床表现、1-3β-D-葡聚糖(BG)和半乳甘露聚糖(GM)抗原结果以及可能的污染源分析。
MALDI-TOF MS-Vitek(法国马西耶图瓦勒的生物梅里埃公司)未能鉴定出6株分离株,而SARAMIS(法国马西耶图瓦勒的生物梅里埃公司)将分离株鉴定为。最初,Vitek 2在7例病例中的2例中将菌株鉴定为。分子鉴定显示与有99%的同源性。6例患者中有3例BG呈阳性(范围为159至>523 pg/ml),GM结果始终为阴性。所有分离株均对棘白菌素(阿尼芬净、米卡芬净和卡泊芬净)和氟康唑耐药,但对氟胞嘧啶和伏立康唑敏感。1株分离株在治疗期间对氟胞嘧啶和两性霉素B获得性耐药。通过MALDI-TOF MS(布鲁克道尔顿公司)和MS-Vitek获得的基于相关性的树状图不仅将7株血流感染(BSI)分离株中的6株聚集在同一组中,还显示了它们之间的强相关性。使用SNPrelate进行的系统发育分析表明,调查期间记录的7个样本聚集在一起。我们观察到1例病例与其余病例之间的分歧,一个节点的支持度为2.3(P值=0.021),每个分支有16个独特的突变。
使用蛋白质组学来鉴定和评估罕见病原体疫情中的菌株克隆性,是一种有前途的替代费力且耗时的分子方法的方法,即使分子全基因组测序(WGS)分型仍将是罕见新兴病原体的参考方法。